Selected research
Industry Growth & Trends
Global Irbesartan Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Irbesartan Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Irbesartan Tablets include Zhuhai Rundu Pharmaceutica, Teva, Sanofi, Jiangsu Hengrui Medicine, Verdant Life Sciences, Taj Pharmaceuticals and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Irbesartan Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Irbesartan Tablets market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Irbesartan Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Irbesartan Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Irbesartan Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Irbesartan Tablets Market by Company
Zhuhai Rundu Pharmaceutica
Teva
Sanofi
Jiangsu Hengrui Medicine
Verdant Life Sciences
Taj Pharmaceuticals
Apotex
Irbesartan Tablets Segment by Type
75 mg Tablets
300 mg Tablets
150 mg Tablets
Irbesartan Tablets Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Irbesartan Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irbesartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irbesartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irbesartan Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irbesartan Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Irbesartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 75 mg Tablets
- 300 mg Tablets
- 150 mg Tablets
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Zhuhai Rundu Pharmaceutica
- Teva
- Sanofi
- Jiangsu Hengrui Medicine
- Verdant Life Sciences
- Taj Pharmaceuticals
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Irbesartan Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Irbesartan Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Irbesartan Tablets Market by Type
- 1.3.1 75 mg Tablets
- 1.3.2 300 mg Tablets
- 1.3.3 150 mg Tablets
- 1.4 Global Irbesartan Tablets Market Size by Type
- 1.4.1 Global Irbesartan Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Irbesartan Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Irbesartan Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Irbesartan Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Irbesartan Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Irbesartan Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Irbesartan Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Irbesartan Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Irbesartan Tablets Industry Trends
- 2.2 Irbesartan Tablets Industry Drivers
- 2.3 Irbesartan Tablets Industry Opportunities and Challenges
- 2.4 Irbesartan Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Irbesartan Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Irbesartan Tablets Sales (2021-2026)
- 3.3 Global Top Players by Irbesartan Tablets Price (2021-2026)
- 3.4 Global Irbesartan Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Irbesartan Tablets Major Company Production Sites & Headquarters
- 3.6 Global Irbesartan Tablets Company, Product Type & Application
- 3.7 Global Irbesartan Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Irbesartan Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Irbesartan Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Irbesartan Tablets Tier 1, Tier 2, and Tier 3
4 Irbesartan Tablets Regional Status and Outlook
- 4.1 Global Irbesartan Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Irbesartan Tablets Historic Market Size by Region
- 4.2.1 Global Irbesartan Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Irbesartan Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Irbesartan Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Irbesartan Tablets Forecasted Market Size by Region
- 4.3.1 Global Irbesartan Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Irbesartan Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Irbesartan Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Irbesartan Tablets by Application
- 5.1 Irbesartan Tablets Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Irbesartan Tablets Market Size by Application
- 5.2.1 Global Irbesartan Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Irbesartan Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Irbesartan Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Irbesartan Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Irbesartan Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Irbesartan Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Irbesartan Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Irbesartan Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhuhai Rundu Pharmaceutica
- 6.1.1 Zhuhai Rundu Pharmaceutica Company Information
- 6.1.2 Zhuhai Rundu Pharmaceutica Business Overview
- 6.1.3 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Product Portfolio
- 6.1.5 Zhuhai Rundu Pharmaceutica Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Irbesartan Tablets Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Irbesartan Tablets Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Jiangsu Hengrui Medicine
- 6.4.1 Jiangsu Hengrui Medicine Company Information
- 6.4.2 Jiangsu Hengrui Medicine Business Overview
- 6.4.3 Jiangsu Hengrui Medicine Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Jiangsu Hengrui Medicine Irbesartan Tablets Product Portfolio
- 6.4.5 Jiangsu Hengrui Medicine Recent Developments
- 6.5 Verdant Life Sciences
- 6.5.1 Verdant Life Sciences Company Information
- 6.5.2 Verdant Life Sciences Business Overview
- 6.5.3 Verdant Life Sciences Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Verdant Life Sciences Irbesartan Tablets Product Portfolio
- 6.5.5 Verdant Life Sciences Recent Developments
- 6.6 Taj Pharmaceuticals
- 6.6.1 Taj Pharmaceuticals Company Information
- 6.6.2 Taj Pharmaceuticals Business Overview
- 6.6.3 Taj Pharmaceuticals Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Taj Pharmaceuticals Irbesartan Tablets Product Portfolio
- 6.6.5 Taj Pharmaceuticals Recent Developments
- 6.7 Apotex
- 6.7.1 Apotex Company Information
- 6.7.2 Apotex Business Overview
- 6.7.3 Apotex Irbesartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Apotex Irbesartan Tablets Product Portfolio
- 6.7.5 Apotex Recent Developments
7 North America by Country
- 7.1 North America Irbesartan Tablets Sales by Country
- 7.1.1 North America Irbesartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Irbesartan Tablets Sales by Country (2021-2026)
- 7.1.3 North America Irbesartan Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Irbesartan Tablets Market Size by Country
- 7.2.1 North America Irbesartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Irbesartan Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Irbesartan Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Irbesartan Tablets Sales by Country
- 8.1.1 Europe Irbesartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Irbesartan Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Irbesartan Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Irbesartan Tablets Market Size by Country
- 8.2.1 Europe Irbesartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Irbesartan Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Irbesartan Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Irbesartan Tablets Sales by Country
- 9.1.1 Asia-Pacific Irbesartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Irbesartan Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Irbesartan Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Irbesartan Tablets Market Size by Country
- 9.2.1 Asia-Pacific Irbesartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Irbesartan Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Irbesartan Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Irbesartan Tablets Sales by Country
- 10.1.1 South America Irbesartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Irbesartan Tablets Sales by Country (2021-2026)
- 10.1.3 South America Irbesartan Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Irbesartan Tablets Market Size by Country
- 10.2.1 South America Irbesartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Irbesartan Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Irbesartan Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Irbesartan Tablets Sales by Country
- 11.1.1 Middle East and Africa Irbesartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Irbesartan Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Irbesartan Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Irbesartan Tablets Market Size by Country
- 11.2.1 Middle East and Africa Irbesartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Irbesartan Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Irbesartan Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Irbesartan Tablets Value Chain Analysis
- 12.1.1 Irbesartan Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Irbesartan Tablets Production Mode & Process
- 12.2 Irbesartan Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Irbesartan Tablets Distributors
- 12.2.3 Irbesartan Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst